

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 8.33806285 |
| 2 | ensheathment of neurons (GO:0007272) | 7.05934614 |
| 3 | axon ensheathment (GO:0008366) | 7.05934614 |
| 4 | myelination (GO:0042552) | 7.03971312 |
| 5 | synaptic vesicle maturation (GO:0016188) | 6.68643047 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.51794356 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.46426997 |
| 8 | glutamate secretion (GO:0014047) | 6.22070692 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.87864119 |
| 10 | myelin maintenance (GO:0043217) | 5.76416237 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 5.69093441 |
| 12 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.47673726 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.30764267 |
| 14 | neuronal ion channel clustering (GO:0045161) | 5.26413814 |
| 15 | sodium ion export (GO:0071436) | 5.19561086 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.12711666 |
| 17 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.05736900 |
| 18 | cholesterol biosynthetic process (GO:0006695) | 4.99145435 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.97678578 |
| 20 | negative regulation of neurotransmitter transport (GO:0051589) | 4.95589446 |
| 21 | establishment of mitochondrion localization (GO:0051654) | 4.94408741 |
| 22 | negative regulation of protein localization to cell surface (GO:2000009) | 4.69999841 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.63974653 |
| 24 | neurotransmitter secretion (GO:0007269) | 4.60772962 |
| 25 | locomotory exploration behavior (GO:0035641) | 4.57186765 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.51535451 |
| 27 | oligodendrocyte differentiation (GO:0048709) | 4.50439889 |
| 28 | glycerophospholipid catabolic process (GO:0046475) | 4.50190107 |
| 29 | response to methylmercury (GO:0051597) | 4.45575204 |
| 30 | sterol biosynthetic process (GO:0016126) | 4.43769761 |
| 31 | creatine metabolic process (GO:0006600) | 4.43481070 |
| 32 | amyloid precursor protein metabolic process (GO:0042982) | 4.41437684 |
| 33 | regulation of collateral sprouting (GO:0048670) | 4.40568228 |
| 34 | potassium ion homeostasis (GO:0055075) | 4.37059594 |
| 35 | potassium ion import (GO:0010107) | 4.35600330 |
| 36 | apical protein localization (GO:0045176) | 4.33455461 |
| 37 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.30309213 |
| 38 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.28805577 |
| 39 | eye photoreceptor cell differentiation (GO:0001754) | 4.23636777 |
| 40 | photoreceptor cell differentiation (GO:0046530) | 4.23636777 |
| 41 | cerebellar granule cell differentiation (GO:0021707) | 4.20240092 |
| 42 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.18649139 |
| 43 | L-amino acid import (GO:0043092) | 4.17258897 |
| 44 | asymmetric protein localization (GO:0008105) | 4.16616266 |
| 45 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.12471536 |
| 46 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.09652777 |
| 47 | astrocyte development (GO:0014002) | 4.06646289 |
| 48 | postsynaptic membrane organization (GO:0001941) | 3.99084160 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.96201875 |
| 50 | isoprenoid biosynthetic process (GO:0008299) | 3.94668853 |
| 51 | presynaptic membrane organization (GO:0097090) | 3.94325515 |
| 52 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.93889033 |
| 53 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.93248716 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.90925401 |
| 55 | neurotransmitter transport (GO:0006836) | 3.88651513 |
| 56 | vocalization behavior (GO:0071625) | 3.86840491 |
| 57 | regulation of lipoprotein metabolic process (GO:0050746) | 3.80156824 |
| 58 | import into cell (GO:0098657) | 3.79889922 |
| 59 | membrane tubulation (GO:0097320) | 3.77122985 |
| 60 | positive regulation of synapse maturation (GO:0090129) | 3.75529314 |
| 61 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.74877440 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.73019166 |
| 63 | substantia nigra development (GO:0021762) | 3.70931281 |
| 64 | exploration behavior (GO:0035640) | 3.70858573 |
| 65 | negative regulation of inclusion body assembly (GO:0090084) | 3.69603466 |
| 66 | synaptic transmission, glutamatergic (GO:0035249) | 3.68024321 |
| 67 | acidic amino acid transport (GO:0015800) | 3.66666312 |
| 68 | response to redox state (GO:0051775) | 3.65020746 |
| 69 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.63738240 |
| 70 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.63314539 |
| 71 | response to lipoprotein particle (GO:0055094) | 3.62506147 |
| 72 | regulation of synaptic plasticity (GO:0048167) | 3.58633893 |
| 73 | regulation of neurotransmitter levels (GO:0001505) | 3.58248832 |
| 74 | regulation of ARF protein signal transduction (GO:0032012) | 3.53870125 |
| 75 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.52605067 |
| 76 | glutamate receptor signaling pathway (GO:0007215) | 3.51830198 |
| 77 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.51670704 |
| 78 | long-term synaptic potentiation (GO:0060291) | 3.51296905 |
| 79 | positive regulation of Rap GTPase activity (GO:0032854) | 3.51222844 |
| 80 | positive regulation of dendritic spine development (GO:0060999) | 3.49933712 |
| 81 | presynaptic membrane assembly (GO:0097105) | 3.48191869 |
| 82 | positive regulation of membrane potential (GO:0045838) | 3.47776990 |
| 83 | gamma-aminobutyric acid transport (GO:0015812) | 3.47383437 |
| 84 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.46842785 |
| 85 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.46825412 |
| 86 | GPI anchor biosynthetic process (GO:0006506) | 3.46470188 |
| 87 | neuron-neuron synaptic transmission (GO:0007270) | 3.46119020 |
| 88 | protein palmitoylation (GO:0018345) | 3.45079107 |
| 89 | magnesium ion transport (GO:0015693) | 3.43560470 |
| 90 | neuromuscular process controlling balance (GO:0050885) | 3.43424022 |
| 91 | regulation of neurotransmitter secretion (GO:0046928) | 3.43301475 |
| 92 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.42150265 |
| 93 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.40922977 |
| 94 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.35880372 |
| 95 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.35656997 |
| 96 | GPI anchor metabolic process (GO:0006505) | 3.35194901 |
| 97 | cellular sodium ion homeostasis (GO:0006883) | 3.34882142 |
| 98 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.29645232 |
| 99 | cell communication by electrical coupling (GO:0010644) | 3.28728485 |
| 100 | L-glutamate transport (GO:0015813) | 3.28054781 |
| 101 | regulation of Rap GTPase activity (GO:0032317) | 3.27359295 |
| 102 | regulation of neurotransmitter transport (GO:0051588) | 3.26422433 |
| 103 | axon development (GO:0061564) | 3.26203862 |
| 104 | very long-chain fatty acid metabolic process (GO:0000038) | 3.25156391 |
| 105 | adhesion of symbiont to host cell (GO:0044650) | 3.20580327 |
| 106 | virion attachment to host cell (GO:0019062) | 3.20580327 |
| 107 | myelination in peripheral nervous system (GO:0022011) | 3.19178904 |
| 108 | peripheral nervous system axon ensheathment (GO:0032292) | 3.19178904 |
| 109 | protein localization to synapse (GO:0035418) | 3.17912082 |
| 110 | adult walking behavior (GO:0007628) | 3.17055425 |
| 111 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.15288093 |
| 112 | phosphorelay signal transduction system (GO:0000160) | 3.13829389 |
| 113 | limb bud formation (GO:0060174) | 3.11679789 |
| 114 | regulation of postsynaptic membrane potential (GO:0060078) | 3.09802744 |
| 115 | synaptic vesicle endocytosis (GO:0048488) | 3.09723453 |
| 116 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.09123128 |
| 117 | glycosylceramide metabolic process (GO:0006677) | 3.08991351 |
| 118 | long-term memory (GO:0007616) | 3.08139866 |
| 119 | regulation of dendritic spine development (GO:0060998) | 3.07515368 |
| 120 | amyloid precursor protein catabolic process (GO:0042987) | 3.05877101 |
| 121 | regulation of synaptic transmission (GO:0050804) | 3.02498969 |
| 122 | regulation of synapse structural plasticity (GO:0051823) | 3.02245463 |
| 123 | neurotransmitter uptake (GO:0001504) | 3.01847198 |
| 124 | regulation of synapse maturation (GO:0090128) | 3.01305096 |
| 125 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.00192372 |
| 126 | neuron remodeling (GO:0016322) | 2.99748745 |
| 127 | protein neddylation (GO:0045116) | 2.99107825 |
| 128 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.97439619 |
| 129 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.97264516 |
| 130 | amino acid import (GO:0043090) | 2.96675264 |
| 131 | negative regulation of JUN kinase activity (GO:0043508) | 2.96341298 |
| 132 | membrane depolarization during action potential (GO:0086010) | 2.95922440 |
| 133 | negative regulation of axonogenesis (GO:0050771) | 2.93309843 |
| 134 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.93077873 |
| 135 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.89447553 |
| 136 | peptidyl-cysteine modification (GO:0018198) | 2.88078818 |
| 137 | cell differentiation in hindbrain (GO:0021533) | 2.88076298 |
| 138 | regulation of vesicle fusion (GO:0031338) | 2.87625634 |
| 139 | nucleotide transmembrane transport (GO:1901679) | 2.87205197 |
| 140 | membrane assembly (GO:0071709) | 2.86598156 |
| 141 | thioester biosynthetic process (GO:0035384) | 2.86524575 |
| 142 | acyl-CoA biosynthetic process (GO:0071616) | 2.86524575 |
| 143 | positive regulation of glial cell differentiation (GO:0045687) | 2.86260473 |
| 144 | auditory behavior (GO:0031223) | 2.86215262 |
| 145 | organ growth (GO:0035265) | 2.85665178 |
| 146 | membrane depolarization (GO:0051899) | 2.85471451 |
| 147 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.83322592 |
| 148 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.78646861 |
| 149 | heme transport (GO:0015886) | 2.77989474 |
| 150 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.77561514 |
| 151 | glial cell development (GO:0021782) | 2.77310920 |
| 152 | iron coordination entity transport (GO:1901678) | 2.75268210 |
| 153 | peripheral nervous system development (GO:0007422) | 2.70745199 |
| 154 | positive regulation of action potential (GO:0045760) | 2.70533574 |
| 155 | nerve growth factor signaling pathway (GO:0038180) | 2.70169370 |
| 156 | positive regulation of gliogenesis (GO:0014015) | 2.65840945 |
| 157 | microtubule polymerization or depolymerization (GO:0031109) | 2.65669280 |
| 158 | positive regulation of pseudopodium assembly (GO:0031274) | 2.65660819 |
| 159 | Golgi to endosome transport (GO:0006895) | 2.63437470 |
| 160 | negative regulation of macroautophagy (GO:0016242) | 2.62985415 |
| 161 | enteric nervous system development (GO:0048484) | 2.62245252 |
| 162 | response to lead ion (GO:0010288) | 2.58330480 |
| 163 | tissue regeneration (GO:0042246) | 2.56793039 |
| 164 | transmission of nerve impulse (GO:0019226) | 2.56185867 |
| 165 | negative regulation of chemokine production (GO:0032682) | 2.55535471 |
| 166 | neuronal action potential propagation (GO:0019227) | 2.55457631 |
| 167 | neuron cell-cell adhesion (GO:0007158) | 2.55120096 |
| 168 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.52934997 |
| 169 | L-phenylalanine catabolic process (GO:0006559) | 2.52933809 |
| 170 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.52933809 |
| 171 | response to dietary excess (GO:0002021) | 2.52412176 |
| 172 | lateral sprouting from an epithelium (GO:0060601) | 2.51197966 |
| 173 | regulation of somitogenesis (GO:0014807) | 2.50823020 |
| 174 | protein localization to endosome (GO:0036010) | 2.49945710 |
| 175 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.49636158 |
| 176 | negative regulation of acute inflammatory response (GO:0002674) | 2.49131009 |
| 177 | central nervous system myelination (GO:0022010) | 12.7329902 |
| 178 | axon ensheathment in central nervous system (GO:0032291) | 12.7329902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.29099049 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.00642678 |
| 3 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.80082975 |
| 4 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.79185075 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.42457015 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.40327298 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.36822217 |
| 8 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.24073816 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.23146014 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.21503666 |
| 11 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.17664899 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16937060 |
| 13 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.14325453 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.07327901 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01854152 |
| 16 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93993631 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.91891380 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.89525566 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.89190018 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.89151980 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.89019601 |
| 22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87733031 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.87721088 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.83549272 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.83549272 |
| 26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80827075 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.78833763 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76504572 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75280473 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.73930315 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.73878560 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.72260258 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.72146696 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70340329 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64893727 |
| 36 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.63549267 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.60034105 |
| 38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56776135 |
| 39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.55596528 |
| 40 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.55582107 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53527678 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.52176674 |
| 43 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.51054035 |
| 44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.50439684 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.46938551 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.44736390 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43647156 |
| 48 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40868354 |
| 49 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.38949437 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38906632 |
| 51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.37138673 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36985175 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.36581506 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36188208 |
| 55 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35829989 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.34247371 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33574624 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.33548767 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33228905 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30246011 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.29706228 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.29706228 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28990149 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28473250 |
| 65 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.27143184 |
| 66 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.27096205 |
| 67 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26427070 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25678167 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25502350 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24944477 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22307520 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.21658163 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.20590228 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.20135971 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17481391 |
| 76 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13886522 |
| 77 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13764995 |
| 78 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.13341004 |
| 79 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12930380 |
| 80 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11722357 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10799667 |
| 82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10511196 |
| 83 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10240807 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.10023361 |
| 85 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.09848016 |
| 86 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09241280 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08994349 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07246152 |
| 89 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.07195957 |
| 90 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07010672 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06361391 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05921857 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04758466 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04462482 |
| 95 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04260474 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04237835 |
| 97 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03673725 |
| 98 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03636489 |
| 99 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03349483 |
| 100 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02691833 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02050760 |
| 102 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.01681484 |
| 103 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00961977 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00493036 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99796212 |
| 106 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98923573 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98534759 |
| 108 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97781037 |
| 109 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97781037 |
| 110 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97502134 |
| 111 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97269292 |
| 112 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97242840 |
| 113 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.96463328 |
| 114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96271709 |
| 115 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.95572252 |
| 116 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95466565 |
| 117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95270693 |
| 118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95060579 |
| 119 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.94873072 |
| 120 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94864014 |
| 121 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94839454 |
| 122 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.94499124 |
| 123 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94200638 |
| 124 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93746546 |
| 125 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93260307 |
| 126 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92831579 |
| 127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92815342 |
| 128 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.92429232 |
| 129 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90916038 |
| 130 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90787124 |
| 131 | TBL1_22424771_ChIP-Seq_293T_Human | 0.90483764 |
| 132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90120876 |
| 133 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89721555 |
| 134 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89190623 |
| 135 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89044555 |
| 136 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87724748 |
| 137 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87488597 |
| 138 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87141634 |
| 139 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86944904 |
| 140 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86172455 |
| 141 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85876157 |
| 142 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.81377156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.80351209 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.02272930 |
| 3 | MP0003880_abnormal_central_pattern | 3.68931192 |
| 4 | MP0004270_analgesia | 3.31186713 |
| 5 | MP0003690_abnormal_glial_cell | 3.26270542 |
| 6 | MP0001529_abnormal_vocalization | 2.84262203 |
| 7 | MP0003329_amyloid_beta_deposits | 2.82696974 |
| 8 | MP0003136_yellow_coat_color | 2.74857211 |
| 9 | MP0004742_abnormal_vestibular_system | 2.61724530 |
| 10 | MP0005171_absent_coat_pigmentation | 2.61626434 |
| 11 | MP0004885_abnormal_endolymph | 2.61257007 |
| 12 | MP0001905_abnormal_dopamine_level | 2.55332774 |
| 13 | MP0002272_abnormal_nervous_system | 2.46069518 |
| 14 | MP0001486_abnormal_startle_reflex | 2.38647957 |
| 15 | MP0003634_abnormal_glial_cell | 2.37220320 |
| 16 | MP0004142_abnormal_muscle_tone | 2.30744821 |
| 17 | MP0005409_darkened_coat_color | 2.25688972 |
| 18 | MP0001485_abnormal_pinna_reflex | 2.17953212 |
| 19 | MP0002064_seizures | 2.08343424 |
| 20 | MP0005410_abnormal_fertilization | 2.07507200 |
| 21 | MP0000778_abnormal_nervous_system | 2.03405154 |
| 22 | MP0002229_neurodegeneration | 1.88807358 |
| 23 | MP0003632_abnormal_nervous_system | 1.86668969 |
| 24 | MP0004043_abnormal_pH_regulation | 1.86660344 |
| 25 | MP0010678_abnormal_skin_adnexa | 1.85796550 |
| 26 | MP0005423_abnormal_somatic_nervous | 1.84182475 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.81270969 |
| 28 | MP0001984_abnormal_olfaction | 1.80295395 |
| 29 | MP0003879_abnormal_hair_cell | 1.79995848 |
| 30 | MP0005451_abnormal_body_composition | 1.72339687 |
| 31 | MP0004381_abnormal_hair_follicle | 1.69625072 |
| 32 | MP0000383_abnormal_hair_follicle | 1.68403924 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.67739360 |
| 34 | MP0004859_abnormal_synaptic_plasticity | 1.66118045 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.65828331 |
| 36 | MP0000462_abnormal_digestive_system | 1.60388414 |
| 37 | MP0009046_muscle_twitch | 1.59955507 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.58835729 |
| 39 | MP0003787_abnormal_imprinting | 1.58219854 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 1.57815080 |
| 41 | MP0009745_abnormal_behavioral_response | 1.54791542 |
| 42 | MP0003631_nervous_system_phenotype | 1.52061873 |
| 43 | MP0008260_abnormal_autophagy | 1.50969603 |
| 44 | MP0004134_abnormal_chest_morphology | 1.50596082 |
| 45 | MP0003635_abnormal_synaptic_transmissio | 1.49259597 |
| 46 | MP0002736_abnormal_nociception_after | 1.46569769 |
| 47 | MP0000604_amyloidosis | 1.46296330 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.42102441 |
| 49 | MP0004147_increased_porphyrin_level | 1.40192572 |
| 50 | MP0000566_synostosis | 1.37777712 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.36149333 |
| 52 | MP0003633_abnormal_nervous_system | 1.35978982 |
| 53 | MP0000955_abnormal_spinal_cord | 1.35387898 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.27770929 |
| 55 | MP0003195_calcinosis | 1.26418102 |
| 56 | MP0001346_abnormal_lacrimal_gland | 1.25399967 |
| 57 | MP0005167_abnormal_blood-brain_barrier | 1.22199303 |
| 58 | MP0001963_abnormal_hearing_physiology | 1.21376709 |
| 59 | MP0002572_abnormal_emotion/affect_behav | 1.21059474 |
| 60 | MP0008569_lethality_at_weaning | 1.18499762 |
| 61 | MP0001440_abnormal_grooming_behavior | 1.18490684 |
| 62 | MP0002066_abnormal_motor_capabilities/c | 1.17822437 |
| 63 | MP0001970_abnormal_pain_threshold | 1.15411809 |
| 64 | MP0000747_muscle_weakness | 1.14984099 |
| 65 | MP0002752_abnormal_somatic_nervous | 1.10962487 |
| 66 | MP0002063_abnormal_learning/memory/cond | 1.09604610 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.07182917 |
| 68 | MP0004924_abnormal_behavior | 1.07182917 |
| 69 | MP0001851_eye_inflammation | 1.06195306 |
| 70 | MP0001299_abnormal_eye_distance/ | 1.05157088 |
| 71 | MP0002067_abnormal_sensory_capabilities | 1.05151807 |
| 72 | MP0000647_abnormal_sebaceous_gland | 1.03868970 |
| 73 | MP0003075_altered_response_to | 1.03126236 |
| 74 | MP0005623_abnormal_meninges_morphology | 1.02080501 |
| 75 | MP0005195_abnormal_posterior_eye | 1.01949546 |
| 76 | MP0008874_decreased_physiological_sensi | 1.00509998 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.00288310 |
| 78 | MP0000762_abnormal_tongue_morphology | 0.99475029 |
| 79 | MP0006276_abnormal_autonomic_nervous | 0.98194666 |
| 80 | MP0001661_extended_life_span | 0.96731864 |
| 81 | MP0003938_abnormal_ear_development | 0.95881778 |
| 82 | MP0002295_abnormal_pulmonary_circulatio | 0.93135920 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.92973894 |
| 84 | MP0005408_hypopigmentation | 0.91232938 |
| 85 | MP0003937_abnormal_limbs/digits/tail_de | 0.91068838 |
| 86 | MP0001177_atelectasis | 0.89637589 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.89049092 |
| 88 | MP0003123_paternal_imprinting | 0.87043313 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.85651389 |
| 90 | MP0006082_CNS_inflammation | 0.84268523 |
| 91 | MP0002733_abnormal_thermal_nociception | 0.83522598 |
| 92 | MP0003122_maternal_imprinting | 0.81563185 |
| 93 | MP0000579_abnormal_nail_morphology | 0.81382600 |
| 94 | MP0003045_fibrosis | 0.79946921 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.79287565 |
| 96 | MP0000026_abnormal_inner_ear | 0.78381286 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.75242552 |
| 98 | MP0002152_abnormal_brain_morphology | 0.74781504 |
| 99 | MP0004036_abnormal_muscle_relaxation | 0.73640652 |
| 100 | MP0005253_abnormal_eye_physiology | 0.73167837 |
| 101 | MP0008438_abnormal_cutaneous_collagen | 0.71611392 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.70658105 |
| 103 | MP0002735_abnormal_chemical_nociception | 0.68682559 |
| 104 | MP0006072_abnormal_retinal_apoptosis | 0.68515855 |
| 105 | MP0000467_abnormal_esophagus_morphology | 0.67352129 |
| 106 | MP0009840_abnormal_foam_cell | 0.66218791 |
| 107 | MP0001968_abnormal_touch/_nociception | 0.64681231 |
| 108 | MP0005535_abnormal_body_temperature | 0.64593269 |
| 109 | MP0005388_respiratory_system_phenotype | 0.62299404 |
| 110 | MP0002133_abnormal_respiratory_system | 0.62299404 |
| 111 | MP0002069_abnormal_eating/drinking_beha | 0.61483646 |
| 112 | MP0001340_abnormal_eyelid_morphology | 0.61165310 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.60134082 |
| 114 | MP0001502_abnormal_circadian_rhythm | 0.59654868 |
| 115 | MP0004133_heterotaxia | 0.59027681 |
| 116 | MP0002822_catalepsy | 0.58012008 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.57879811 |
| 118 | MP0002184_abnormal_innervation | 0.56936542 |
| 119 | MP0002909_abnormal_adrenal_gland | 0.56101414 |
| 120 | MP0009250_abnormal_appendicular_skeleto | 0.55571134 |
| 121 | MP0003137_abnormal_impulse_conducting | 0.54708336 |
| 122 | MP0004130_abnormal_muscle_cell | 0.54649885 |
| 123 | MP0010769_abnormal_survival | 0.54171177 |
| 124 | MP0008872_abnormal_physiological_respon | 0.51971906 |
| 125 | MP0002082_postnatal_lethality | 0.50749286 |
| 126 | MP0010770_preweaning_lethality | 0.50749286 |
| 127 | MP0010768_mortality/aging | 0.50618369 |
| 128 | MP0001943_abnormal_respiration | 0.48926755 |
| 129 | MP0008877_abnormal_DNA_methylation | 0.47840495 |
| 130 | MP0005166_decreased_susceptibility_to | 0.43874929 |
| 131 | MP0000639_abnormal_adrenal_gland | 0.43449495 |
| 132 | MP0003956_abnormal_body_size | 0.42892395 |
| 133 | MP0003172_abnormal_lysosome_physiology | 0.42482777 |
| 134 | MP0010386_abnormal_urinary_bladder | 0.39914978 |
| 135 | MP0002083_premature_death | 0.39253804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 7.02251328 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 7.02251328 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.38924544 |
| 4 | Focal motor seizures (HP:0011153) | 6.25728717 |
| 5 | Action tremor (HP:0002345) | 5.35030214 |
| 6 | Abnormality of the corticospinal tract (HP:0002492) | 5.14491236 |
| 7 | Focal seizures (HP:0007359) | 5.04070991 |
| 8 | Parakeratosis (HP:0001036) | 4.90959143 |
| 9 | Febrile seizures (HP:0002373) | 4.63753395 |
| 10 | Diplopia (HP:0000651) | 4.59623511 |
| 11 | Abnormality of binocular vision (HP:0011514) | 4.59623511 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 4.53926160 |
| 13 | Peripheral hypomyelination (HP:0007182) | 4.50239954 |
| 14 | Sensory axonal neuropathy (HP:0003390) | 4.36655398 |
| 15 | Epileptic encephalopathy (HP:0200134) | 4.34483684 |
| 16 | Atonic seizures (HP:0010819) | 4.32557122 |
| 17 | Onion bulb formation (HP:0003383) | 3.98335601 |
| 18 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.90990177 |
| 19 | Cerebral hypomyelination (HP:0006808) | 3.78103022 |
| 20 | Termporal pattern (HP:0011008) | 3.67151386 |
| 21 | Insidious onset (HP:0003587) | 3.67151386 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.65083531 |
| 23 | Spastic gait (HP:0002064) | 3.59784142 |
| 24 | Postural instability (HP:0002172) | 3.46601903 |
| 25 | Abnormal auditory evoked potentials (HP:0006958) | 3.44609181 |
| 26 | Abnormal eating behavior (HP:0100738) | 3.34423490 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.30071796 |
| 28 | Increased serum pyruvate (HP:0003542) | 3.22192695 |
| 29 | Abnormality of glycolysis (HP:0004366) | 3.22192695 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.18239275 |
| 31 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.10113666 |
| 32 | Progressive cerebellar ataxia (HP:0002073) | 3.09344224 |
| 33 | Alacrima (HP:0000522) | 3.09225277 |
| 34 | Dysmetria (HP:0001310) | 3.08066559 |
| 35 | Intention tremor (HP:0002080) | 3.04853335 |
| 36 | Absence seizures (HP:0002121) | 3.03593175 |
| 37 | Retinal dysplasia (HP:0007973) | 3.03054966 |
| 38 | Papilledema (HP:0001085) | 3.02971471 |
| 39 | Leukodystrophy (HP:0002415) | 3.02860074 |
| 40 | Dialeptic seizures (HP:0011146) | 3.01738524 |
| 41 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.01251371 |
| 42 | Limb dystonia (HP:0002451) | 2.98136614 |
| 43 | Visual hallucinations (HP:0002367) | 2.96388686 |
| 44 | Hemiplegia (HP:0002301) | 2.93565885 |
| 45 | Ankle clonus (HP:0011448) | 2.89887019 |
| 46 | Truncal ataxia (HP:0002078) | 2.87840748 |
| 47 | Obstructive sleep apnea (HP:0002870) | 2.85491699 |
| 48 | Scanning speech (HP:0002168) | 2.84925688 |
| 49 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.83826633 |
| 50 | Anteriorly placed anus (HP:0001545) | 2.79910802 |
| 51 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.78841480 |
| 52 | Slow saccadic eye movements (HP:0000514) | 2.75287705 |
| 53 | Torticollis (HP:0000473) | 2.70959954 |
| 54 | Neuronal loss in central nervous system (HP:0002529) | 2.69144961 |
| 55 | Stridor (HP:0010307) | 2.68311156 |
| 56 | Myokymia (HP:0002411) | 2.67321109 |
| 57 | Autoamputation (HP:0001218) | 2.66661228 |
| 58 | Dysdiadochokinesis (HP:0002075) | 2.65739850 |
| 59 | Absent septum pellucidum (HP:0001331) | 2.62390366 |
| 60 | Hemiparesis (HP:0001269) | 2.61591362 |
| 61 | Mutism (HP:0002300) | 2.60080909 |
| 62 | Tetraplegia (HP:0002445) | 2.59993649 |
| 63 | Thickened helices (HP:0000391) | 2.59132504 |
| 64 | Cerebral hemorrhage (HP:0001342) | 2.57375106 |
| 65 | Clumsiness (HP:0002312) | 2.50170530 |
| 66 | Hypoplastic pelvis (HP:0008839) | 2.45310041 |
| 67 | CNS hypomyelination (HP:0003429) | 2.43914719 |
| 68 | Rigidity (HP:0002063) | 2.43563712 |
| 69 | Bradykinesia (HP:0002067) | 2.42712746 |
| 70 | Spastic paraparesis (HP:0002313) | 2.41299878 |
| 71 | Decreased lacrimation (HP:0000633) | 2.39733440 |
| 72 | Bundle branch block (HP:0011710) | 2.39596167 |
| 73 | Status epilepticus (HP:0002133) | 2.39132560 |
| 74 | Premature skin wrinkling (HP:0100678) | 2.38372987 |
| 75 | Sleep apnea (HP:0010535) | 2.38171617 |
| 76 | Apathy (HP:0000741) | 2.37920476 |
| 77 | Depression (HP:0000716) | 2.37435245 |
| 78 | Delusions (HP:0000746) | 2.37059969 |
| 79 | Abnormality of the periventricular white matter (HP:0002518) | 2.35954124 |
| 80 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.35865203 |
| 81 | Morphological abnormality of the inner ear (HP:0011390) | 2.34200571 |
| 82 | Annular pancreas (HP:0001734) | 2.34114199 |
| 83 | Split foot (HP:0001839) | 2.33737500 |
| 84 | Rapidly progressive (HP:0003678) | 2.33441631 |
| 85 | Spastic paraplegia (HP:0001258) | 2.31764071 |
| 86 | Metabolic alkalosis (HP:0200114) | 2.31254976 |
| 87 | Pheochromocytoma (HP:0002666) | 2.30055303 |
| 88 | Poor eye contact (HP:0000817) | 2.29651865 |
| 89 | Increased circulating renin level (HP:0000848) | 2.28918526 |
| 90 | Paraplegia (HP:0010550) | 2.27719740 |
| 91 | Hepatosplenomegaly (HP:0001433) | 2.26999602 |
| 92 | Axonal loss (HP:0003447) | 2.26050889 |
| 93 | Epileptiform EEG discharges (HP:0011182) | 2.25219022 |
| 94 | Spastic tetraparesis (HP:0001285) | 2.24330958 |
| 95 | Abnormality of the septum pellucidum (HP:0007375) | 2.24155288 |
| 96 | Foot dorsiflexor weakness (HP:0009027) | 2.23757683 |
| 97 | Aplasia involving bones of the extremities (HP:0009825) | 2.22515698 |
| 98 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.22515698 |
| 99 | Aplasia of the phalanges of the hand (HP:0009802) | 2.22515698 |
| 100 | Akinesia (HP:0002304) | 2.22334653 |
| 101 | Anxiety (HP:0000739) | 2.21345527 |
| 102 | Insomnia (HP:0100785) | 2.18705494 |
| 103 | Lower limb muscle weakness (HP:0007340) | 2.18562068 |
| 104 | Patchy hypopigmentation of hair (HP:0011365) | 2.18561483 |
| 105 | Coronal craniosynostosis (HP:0004440) | 2.18224755 |
| 106 | Muscle fiber splitting (HP:0003555) | 2.17111776 |
| 107 | White forelock (HP:0002211) | 2.16943733 |
| 108 | Focal dystonia (HP:0004373) | 2.12582645 |
| 109 | Hypomagnesemia (HP:0002917) | 2.09951620 |
| 110 | Diminished motivation (HP:0000745) | 2.09511944 |
| 111 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.09070083 |
| 112 | Methylmalonic acidemia (HP:0002912) | 2.07416107 |
| 113 | Hypoplasia of the iris (HP:0007676) | 2.06895787 |
| 114 | Infantile muscular hypotonia (HP:0008947) | 2.06771780 |
| 115 | Decreased motor nerve conduction velocity (HP:0003431) | 2.06211939 |
| 116 | Hypophosphatemic rickets (HP:0004912) | 2.04536815 |
| 117 | Hypokalemic alkalosis (HP:0001949) | 2.04075155 |
| 118 | Abnormality of the foot musculature (HP:0001436) | 2.03521940 |
| 119 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.01364510 |
| 120 | Impaired vibratory sensation (HP:0002495) | 2.01272423 |
| 121 | Neuroendocrine neoplasm (HP:0100634) | 2.00482395 |
| 122 | Craniofacial dystonia (HP:0012179) | 2.00357571 |
| 123 | Impaired smooth pursuit (HP:0007772) | 1.99658846 |
| 124 | Partial duplication of thumb phalanx (HP:0009944) | 1.99143279 |
| 125 | Memory impairment (HP:0002354) | 1.98649056 |
| 126 | Megalencephaly (HP:0001355) | 1.98443834 |
| 127 | Renal Fanconi syndrome (HP:0001994) | 1.98390398 |
| 128 | Synostosis involving the elbow (HP:0003938) | 1.96422727 |
| 129 | Humeroradial synostosis (HP:0003041) | 1.96422727 |
| 130 | Abnormality of saccadic eye movements (HP:0000570) | 1.95766136 |
| 131 | Cupped ear (HP:0000378) | 1.94683347 |
| 132 | Broad-based gait (HP:0002136) | 1.94613344 |
| 133 | Partial agenesis of the corpus callosum (HP:0001338) | 1.92681154 |
| 134 | EEG with generalized epileptiform discharges (HP:0011198) | 1.91968027 |
| 135 | Esophageal atresia (HP:0002032) | 1.90662871 |
| 136 | Amyotrophic lateral sclerosis (HP:0007354) | 1.90256741 |
| 137 | Abnormal social behavior (HP:0012433) | 1.90117513 |
| 138 | Impaired social interactions (HP:0000735) | 1.90117513 |
| 139 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.89731310 |
| 140 | Gowers sign (HP:0003391) | 1.87312288 |
| 141 | Poor speech (HP:0002465) | 1.87084794 |
| 142 | Bowel incontinence (HP:0002607) | 1.85874562 |
| 143 | Urinary incontinence (HP:0000020) | 1.85673200 |
| 144 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85418077 |
| 145 | Clonus (HP:0002169) | 1.83088324 |
| 146 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.82560671 |
| 147 | Hyporeflexia of lower limbs (HP:0002600) | 1.79420370 |
| 148 | Paraparesis (HP:0002385) | 1.78549137 |
| 149 | Urinary urgency (HP:0000012) | 1.77897315 |
| 150 | Erythroderma (HP:0001019) | 1.77664425 |
| 151 | Hammertoe (HP:0001765) | 1.77390072 |
| 152 | Abnormal large intestine physiology (HP:0012700) | 1.73656529 |
| 153 | Choreoathetosis (HP:0001266) | 1.72413812 |
| 154 | Prolonged neonatal jaundice (HP:0006579) | 1.71633880 |
| 155 | Peripheral demyelination (HP:0011096) | 1.71165054 |
| 156 | Acute necrotizing encephalopathy (HP:0006965) | 1.70058535 |
| 157 | Adrenal hypoplasia (HP:0000835) | 1.69649588 |
| 158 | Distal sensory impairment (HP:0002936) | 1.68570883 |
| 159 | Stenosis of the external auditory canal (HP:0000402) | 1.67860403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.48607294 |
| 2 | OXSR1 | 4.53589982 |
| 3 | NTRK3 | 4.26174172 |
| 4 | EPHB1 | 3.47478966 |
| 5 | DAPK2 | 2.91448499 |
| 6 | MAPKAPK5 | 2.90208013 |
| 7 | PBK | 2.87036551 |
| 8 | BCR | 2.72351069 |
| 9 | PKN1 | 2.67608232 |
| 10 | WNK4 | 2.62013035 |
| 11 | MET | 2.42707417 |
| 12 | CDK19 | 2.38450101 |
| 13 | MINK1 | 2.33489709 |
| 14 | CAMKK1 | 2.21349860 |
| 15 | FGFR2 | 2.19895657 |
| 16 | WNK1 | 2.12447815 |
| 17 | PRKD3 | 2.06481726 |
| 18 | TESK2 | 1.99864820 |
| 19 | LIMK1 | 1.96909404 |
| 20 | MAP3K9 | 1.95354985 |
| 21 | CSNK1G3 | 1.83878035 |
| 22 | RIPK4 | 1.81243374 |
| 23 | PNCK | 1.80441901 |
| 24 | CSNK1A1L | 1.80200499 |
| 25 | UHMK1 | 1.79262120 |
| 26 | MST4 | 1.64088900 |
| 27 | CAMK2B | 1.63539038 |
| 28 | NEK6 | 1.57582799 |
| 29 | CLK1 | 1.45840157 |
| 30 | ROCK2 | 1.44188807 |
| 31 | CSNK1G1 | 1.43726595 |
| 32 | NTRK1 | 1.43099881 |
| 33 | FGR | 1.37479623 |
| 34 | PLK2 | 1.36719706 |
| 35 | TNIK | 1.35847580 |
| 36 | CSNK1G2 | 1.35622974 |
| 37 | CAMK2D | 1.35403696 |
| 38 | SGK494 | 1.25249316 |
| 39 | SGK223 | 1.25249316 |
| 40 | PRPF4B | 1.25002329 |
| 41 | CASK | 1.24525213 |
| 42 | GRK5 | 1.23078730 |
| 43 | CAMK1 | 1.22298491 |
| 44 | SGK2 | 1.18499337 |
| 45 | RIPK1 | 1.15228166 |
| 46 | ICK | 1.14646402 |
| 47 | PAK6 | 1.11398140 |
| 48 | CAMKK2 | 1.08663888 |
| 49 | MAPK10 | 1.07651152 |
| 50 | ALK | 1.06671755 |
| 51 | CAMK2G | 1.05176915 |
| 52 | PRKCG | 1.04394672 |
| 53 | DYRK2 | 1.03792660 |
| 54 | LATS2 | 1.02579031 |
| 55 | SGK3 | 1.01001154 |
| 56 | SGK1 | 0.97823167 |
| 57 | EPHA4 | 0.95607819 |
| 58 | BMPR1B | 0.94245438 |
| 59 | MAPK15 | 0.94050881 |
| 60 | MUSK | 0.90234334 |
| 61 | MARK1 | 0.89896292 |
| 62 | MAPK12 | 0.88745145 |
| 63 | SIK2 | 0.88397020 |
| 64 | MARK2 | 0.85833472 |
| 65 | PAK3 | 0.84785300 |
| 66 | CAMK2A | 0.84661989 |
| 67 | DAPK1 | 0.83915860 |
| 68 | PRKCQ | 0.83046337 |
| 69 | STK38 | 0.81845278 |
| 70 | PRKD1 | 0.79723929 |
| 71 | CDK14 | 0.79078861 |
| 72 | CDK5 | 0.76064179 |
| 73 | RPS6KA5 | 0.71960994 |
| 74 | ARAF | 0.71765409 |
| 75 | TNK2 | 0.71020741 |
| 76 | CDK15 | 0.70550323 |
| 77 | RPS6KA3 | 0.70060668 |
| 78 | ERBB4 | 0.65606791 |
| 79 | PRKCE | 0.65568124 |
| 80 | CDK18 | 0.65219047 |
| 81 | TYRO3 | 0.64847366 |
| 82 | CDK11A | 0.63111548 |
| 83 | PHKG2 | 0.61555862 |
| 84 | PHKG1 | 0.61555862 |
| 85 | TRPM7 | 0.61120753 |
| 86 | MAP3K2 | 0.60847461 |
| 87 | PDPK1 | 0.60166538 |
| 88 | IRAK2 | 0.58751455 |
| 89 | FES | 0.58652033 |
| 90 | MAP3K11 | 0.58471329 |
| 91 | CAMK4 | 0.57114380 |
| 92 | MAP2K2 | 0.56044138 |
| 93 | PRKCZ | 0.55720677 |
| 94 | RET | 0.55304547 |
| 95 | MAP3K4 | 0.54065989 |
| 96 | KSR1 | 0.53866067 |
| 97 | MKNK1 | 0.52933781 |
| 98 | CSNK1D | 0.51497231 |
| 99 | MAP3K1 | 0.51013520 |
| 100 | FYN | 0.50745585 |
| 101 | GSK3A | 0.49483534 |
| 102 | GRK7 | 0.49318329 |
| 103 | MAP3K13 | 0.48306334 |
| 104 | PRKG1 | 0.48027670 |
| 105 | MAP2K4 | 0.45008702 |
| 106 | CSNK1A1 | 0.43696386 |
| 107 | ADRBK2 | 0.42898471 |
| 108 | JAK2 | 0.42849120 |
| 109 | PRKACB | 0.42098376 |
| 110 | BRSK1 | 0.41433341 |
| 111 | PIK3CA | 0.41091171 |
| 112 | CAMK1G | 0.41029363 |
| 113 | RAF1 | 0.40668404 |
| 114 | NTRK2 | 0.40108552 |
| 115 | PRKCH | 0.37406164 |
| 116 | JAK1 | 0.37118634 |
| 117 | PAK1 | 0.36469721 |
| 118 | PRKCA | 0.35328987 |
| 119 | ROCK1 | 0.34643690 |
| 120 | STK11 | 0.34278743 |
| 121 | OBSCN | 0.34003877 |
| 122 | KSR2 | 0.33521148 |
| 123 | PRKCB | 0.32883788 |
| 124 | SRC | 0.30253214 |
| 125 | MAPK7 | 0.28949006 |
| 126 | GSK3B | 0.28938923 |
| 127 | BMPR2 | 0.28909320 |
| 128 | PTK2B | 0.28903027 |
| 129 | ITK | 0.28662944 |
| 130 | PINK1 | 0.28443861 |
| 131 | STK16 | 0.28192620 |
| 132 | MAPK13 | 0.27105449 |
| 133 | PRKACA | 0.26900718 |
| 134 | DYRK1A | 0.25638453 |
| 135 | GRK1 | 0.25465253 |
| 136 | PDGFRB | 0.25373463 |
| 137 | HIPK2 | 0.25095252 |
| 138 | DMPK | 0.25032246 |
| 139 | PDK1 | 0.25002754 |
| 140 | DAPK3 | 0.24955855 |
| 141 | INSR | 0.24833751 |
| 142 | IRAK1 | 0.24824394 |
| 143 | BMX | 0.24812517 |
| 144 | CSNK1E | 0.24030673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.51754857 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.72206434 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.71043264 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.40598213 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.23024788 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.15506288 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.85462334 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69547180 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.52440252 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.39430238 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.38190250 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.34914958 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.13140824 |
| 14 | Protein export_Homo sapiens_hsa03060 | 2.05839061 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.03723289 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.00790597 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.98166162 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.81712040 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.80227876 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66908450 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65648505 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64832767 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.63404806 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.53970143 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.52940624 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.51580455 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.47949507 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44185634 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43322656 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41050166 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40881162 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.37558582 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.35380429 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.30492944 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.26526588 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.24700456 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23012033 |
| 38 | GABAergic synapse_Homo sapiens_hsa04727 | 1.21302302 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21027929 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20200862 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.19742646 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18473893 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15318082 |
| 44 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.12903379 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11176645 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06920929 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02593594 |
| 48 | Glioma_Homo sapiens_hsa05214 | 0.99849044 |
| 49 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.98318904 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97217908 |
| 51 | Long-term depression_Homo sapiens_hsa04730 | 0.94754113 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 0.92514977 |
| 53 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.92233299 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.91567293 |
| 55 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.91143273 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87159314 |
| 57 | Tight junction_Homo sapiens_hsa04530 | 0.86645822 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84567343 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84377300 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.84184594 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83916299 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.83469728 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83018099 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82124524 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78524644 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78396646 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78363216 |
| 68 | Cocaine addiction_Homo sapiens_hsa05030 | 0.77320059 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76333209 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74423275 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73699772 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73420741 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70881074 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69759151 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68837505 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67502292 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67101691 |
| 78 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66791485 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66616330 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65987347 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65490397 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65223326 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64993649 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64862751 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64357760 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.64281862 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63681802 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63533130 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.63329973 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.61901819 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60718705 |
| 92 | Circadian entrainment_Homo sapiens_hsa04713 | 0.60528652 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59742889 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57104436 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55057962 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54524050 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.54206627 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.54041079 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.53126304 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52797844 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52429274 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52248709 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51762609 |
| 104 | ABC transporters_Homo sapiens_hsa02010 | 0.51130761 |
| 105 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50822949 |
| 106 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50704144 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50590978 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50126957 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49120476 |
| 110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48590848 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46853935 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45629496 |
| 113 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45390673 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.45253753 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44256033 |
| 116 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.42113130 |
| 117 | Nicotine addiction_Homo sapiens_hsa05033 | 0.41638201 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40321755 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40100761 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38152309 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38061376 |
| 122 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38000718 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37191036 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.35278601 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34614077 |
| 126 | Renin secretion_Homo sapiens_hsa04924 | 0.34228492 |
| 127 | Malaria_Homo sapiens_hsa05144 | 0.33769971 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33445773 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32699909 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32613978 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32499838 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32342851 |
| 133 | Taste transduction_Homo sapiens_hsa04742 | 0.30461398 |
| 134 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.29633467 |
| 135 | Gap junction_Homo sapiens_hsa04540 | 0.29119859 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27510509 |
| 137 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27406579 |
| 138 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.26555800 |
| 139 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25994501 |
| 140 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.23430834 |
| 141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.23070393 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.22499177 |
| 143 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22444570 |
| 144 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.21538788 |
| 145 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.21454644 |
| 146 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.21286259 |

